This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a bromopyridine moiety, makes it valuable in the development of drugs targeting neurological disorders, particularly those involving the modulation of neurotransmitter systems. It is also employed in the research and development of selective enzyme inhibitors, which are crucial in treating conditions like inflammation and cancer. Additionally, its chiral nature allows for the production of enantiomerically pure compounds, enhancing the efficacy and specificity of therapeutic agents.